Global Coronary Stents Industry ( NEW YORK Dec. 8 2011 /- Reportlinker....)

Global Coronary Stents Industry

Date:12/8/2011

NEW YORK, Dec. 8, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Coronary Stents Industry

http://www.reportlinker.com/p098248/Global-Coronary-Stents-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovas

This report analyzes the worldwide markets for Coronary Stents in US$ Million and Thousand Units by the following Product Segments: Bare Metal Stents, and Drug Eluting Stents. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets.The report profiles 53 companies including many key and niche players such as Angiotech Pharmaceuticals, Abbott Vascular, Biosensors International, Boston Scientific Corp., Cordis Corporation, Medtronic, Inc., Medtronic Cardiovascular, Inc., OrbusNeich, and Terumo Europe N.V. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 3

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

Bare Metal Stents 3

Drug Eluting Stents 4

2. GLOBAL MARKET OVERVIEW 5

Growth Revives as Drug Eluting Stents Bounce Back 5

What's Next on Cards in Coronary Stent Market? 5

Market Snapshots 6

Current and Future Analysis 7'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)

Post Your Comments:

(Date:5/22/2013)... , May 22, 2013 Team Health Holdings ... the largest suppliers of outsourced healthcare professional staffing and ... the United States , today announced ... Annual Deutsche Bank Healthcare Conference held on May 29, ... begin at 8:00 AM eastern time. Interested investors and ...

(Date:5/22/2013)... N.Y. , May 22, 2013 The Leukemia ... million to Valor Biotherapeutics, LLC, a joint venture ... pre-clinical development, manufacturing, and a Phase I clinical trial ... poor outcomes faced by many patients with indolent lymphomas ... Valor,s protein, IGN002, is a new ...

(Date:5/22/2013)... , May 22, 2013 The new 13-valent ... as the previous version used prior to 2010, the ... Permanente study published today in Vaccine. The ... beginning in 2010 after a series of trials. These ... range of pneumococcal types than the previously used PCV7, ...

Breaking Medicine Technology:Team Health Holdings Inc. to Present at the 38th Annual Deutsche Bank Healthcare Conference 2 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4 Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2 Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3 Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4

[0] Team Health Holdings Inc. to Present at the 38th Annual Deutsche Bank Healthcare Conference [0] The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients [0] Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine

... Attend ROTH Fall Conference at Maui, Hawaii From September 1 -... -- CHENGDU, China, Aug. 30 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by ...

... 30 Phase 3 safety and efficacy data comparing tapentadol ... in patients with moderate to severe chronic osteoarthritis knee pain ... addition, this study compared oxycodone controlled release (CR) to placebo ... ER vs. Placebo The study demonstrated ...

Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain

(Date:5/22/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- Anyone who ... something about feet that fungi seem to like. But ... fungal groups that live on your skin -- and, ... It,s no secret that the human body is awash ... both outside and inside. And it,s mainly a friendly ...

(Date:5/22/2013)... New York, New York (PRWEB) May 22, 2013 ... a metal-on-metal version of the DePuy Pinnacle Hip Replacement ... underway in Texas Federal Court, Bernstein Liebhard LLP reports. ... Court has directed DePuy Orthopaedics to produce monitoring reports ... government into the company’s medical device marketing practices. ...

(Date:5/22/2013)... City, UT (PRWEB) May 22, 2013 ... the Alabama Health Insurance Exchange . Zane Benefits, ... sponsored health benefits, is the leader in defined ... , According to Zane Benefits’ website, beginning in 2014 ... insurance coverage for individuals and small businesses will become ...

(Date:5/22/2013)... researchers report that hospitals may be reaping enormous ... by preventable bloodstream infections contracted in their intensive ... reported online in the American Journal of ... ICU patient who develops an avoidable central line-associated ... to care for than a similar infection-free patient. ...

(Date:5/22/2013)... Registered Dietitian and Founder of Tatalou Science ... sharing a recipe for making energy bars at home. , ... ,” takes a recipe modified from one recently featured ... day it gets more and more difficult to understand what ... size of the nutrition label continues to grow and consumers ...

Breaking Medicine News(10 mins):Health News:Scientists Map the Fungi on Your Feet 2 Health News:Scientists Map the Fungi on Your Feet 3 Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2 Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3 Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2 Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3 Health News:Hospitals profit when patients develop bloodstream infections 2 Health News:Hospitals profit when patients develop bloodstream infections 3 Health News:Hospitals profit when patients develop bloodstream infections 4 Health News:How To "Make Your Own Healthy Energy Bars" 2

[0] Scientists Map the Fungi on Your Feet [0] DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation [0] Zane Benefits Publishes New Information on Alabama Health Insurance Exchange [0] Hospitals profit when patients develop bloodstream infections [0] How To "Make Your Own Healthy Energy Bars"

... A community-based maternal health delivery strategy known as the ... maternal health care services for internally displaced woman in ... at the Johns Hopkins Bloomberg School of Public Health. ... in the proportion of women assisted at delivery by ...

... Reporter , TUESDAY, Aug. 3 (HealthDay News) -- America,s waistline ... every 10 adults (26.7 percent) is now statistically obese, up ... report released Tuesday. The report, from the ... that between 2007-2009, the number of U.S. states where at ...

... the residents of Florida, Maine and Massachusetts believe the ... 100 years (81 percent, 78 percent and 84 percent, ... greenhouse gas emissions, according to new public opinion research ... Woods Institute for the Environment at Stanford University. ...

... at Boston University School of Medicine (BUSM) have reported ... a greater likelihood of developing breast cancer than nonusers. ... Cancer Epidemiology Biomarkers and Prevention , were based on ... large follow-up study of 59,000 African American women from ...

... State University biologist and mathematician have joined forces to ... of the hormone prolactin from the pituitary gland, research ... of disorders, including infertility. Marc Freeman, the ... Research Professor Emeritus, and mathematics Professor Richard Bertram have ...

... famed for their ability to mimic sounds and now researchers ... male contact calls when deciding on a mate. The research, ... difference between birds ,songs, and ,calls,. Parrots are ... ability to quickly learn and mimic new sounds, but the ...

Cached Medicine News:Health News:Mobile obstetrics project improves health of mothers in Eastern Burma 2 Health News:Number of Obese Adults Keeps Rising, CDC Says 2 Health News:Number of Obese Adults Keeps Rising, CDC Says 3 Health News:New state surveys affirm Americans' support for government action on climate change 2 Health News:New state surveys affirm Americans' support for government action on climate change 3 Health News:Oral contraceptive use associated with increased risk of breast cancer 2 Health News:FSU study takes novel approach to understanding pituitary function 2 Health News:FSU study takes novel approach to understanding pituitary function 3 Health News:'Virtual mates' reveal role of romance in parrot calls 2

Mobile obstetrics project improves health of mothers in Eastern Burma Number of Obese Adults Keeps Rising, CDC Says New state surveys affirm Americans' support for government action on climate change Oral contraceptive use associated with increased risk of breast cancer FSU study takes novel approach to understanding pituitary function 'Virtual mates' reveal role of romance in parrot calls

... Alert Detection Reagents provide molecular labs a ... assays. By using our MGB technology, combined ... is now able to provide molecular labs ... sequences of specific organisms or genetic mutations ...

... ASRs* are specifically designed for PCR ... two-color fluorescence detection systems. The NGEN ... detection of mutations associated with cystic ... well as reagents for the detection ...

... NGEN-brand ASRs* are specifically designed for ... with two-color fluorescence detection systems. The ... the detection of mutations associated with ... as well as reagents for the ...

Medicine Products:

MGB Alert HHV-6 ASR*NGEN HFE ASRs*MGB Alert CMV ASR*NGEN CFTR ASRs*